Interest-bearing debt
Pass4.0%of market cap
Form 20-F (IFRS), converted from INR at the ECB rate of 2026-11-20
RDYNATIONAL STOCK EXCHANGE OF INDIA
Healthcare · Pharmaceuticals
Verdict
Passes the business-activity screen and all three AAOIFI financial tests, each from Dr Reddy's Laboratories Ltd's own filings.
AAOIFI Shari'ah Standard No. 21 · screened 21 Nov 2026
Each bar shows the figure against its limit; the line marks the limit.
4.0%of market cap
Form 20-F (IFRS), converted from INR at the ECB rate of 2026-11-20
5.0%of market cap
Form 20-F (IFRS), converted from INR at the ECB rate of 2026-11-20
≤ 3.1%of revenue
No prohibited activity (alcohol, gambling, tobacco, conventional finance, pork, adult content) found in the sector, SEC industry or company name.
We couldn’t load historical prices for RDY just now — most often our data provider is briefly rate-limited and a retry in a minute succeeds. If it keeps happening, the symbol may be outside our chart coverage or recently IPO’d. Hero price, fundamentals, and Shariah screening on this page are unaffected.
See the business + financial screening, dividend purification ratio, and category-by-category compliance status.
Upgrade to ProUpper bound: total finance and investment income in the filed statements, which includes interest income. No separate interest-income figure is filed.